Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer

BACKGROUND: To evaluate the anticancer efficacy of the combination of epigenetic modifiers and cisplatin in human ovarian cancer. METHODS: The effect of trichostatin A (TSA) and 5-aza-2′-deoxycytidine alone or in combination with low-dose cisplatin was evaluated on human ovarian cancer cell lines in...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Meng, F, Sun, G, Zhong, M, Yu, Y, Brewer, M A
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2013
Témata:
Translational Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3593556/
https://ncbi.nlm.nih.gov/pubmed/23370212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky